epirubicin has been researched along with Extravascular Hemolysis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hidaka, H; Inoue, T; Koizumi, W; Kubota, K; Nakazawa, T; Onoue, M; Shibuya, A; Tanaka, Y; Uojima, H; Wada, N | 1 |
Chen, Y; Liu, QX; Luo, JJ; Wang, JH; Yan, ZP | 1 |
2 other study(ies) available for epirubicin and Extravascular Hemolysis
Article | Year |
---|---|
A suspected case of Clostridium perfringens sepsis with intravascular hemolysis after transhepatic arterial chemoembolization: a case report.
Topics: Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Clostridium perfringens; Embolization, Therapeutic; Epirubicin; Fatal Outcome; Hemolysis; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Sepsis | 2019 |
[Transhepatic arterial chemoembolization by epirubicin mixed with microspheres for hepatocellular carcinoma].
Topics: Adult; Aged; Alanine Transaminase; alpha-Fetoproteins; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Fever; Follow-Up Studies; Hemolysis; Humans; Leukocyte Count; Liver Neoplasms; Male; Microspheres; Middle Aged; Serum Albumin; Survival Rate | 2007 |